Automation in Biopharma and the Impact on Workflows

Pharmaceutical Technology editors interview an automation expert from Automata on the benefits of automating entire workflows in analytics versus automating only specific pieces of equipment or only certain processes.

Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1581669&tp_key=e856000811

Event Overview:

In this exclusive Drug Digest video interview, Meg Rivers and Feliza Mirasol, Pharmaceutical Technology editors, discuss the benefits of automating entire workflows in analytics (laboratories) versus automating only specific pieces of equipment or only certain processes with Nick Pattinson, head of product, Automata. What influence or impact would this have on workflows further downstream, such as clinical or commercial manufacturing?

Key Learning Objectives:

• Additional automation approaches and how modular approaches fit into this
• Automation opportunities in pharma (i.e., small molecule) vs. biopharma (i.e., large molecule)
• Whether the level of adoption of automation differs in the industry between pharma and biopharma
• How this trend toward automation in laboratory workflows impacts clinical and commercial drug development and manufacturing

Speakers:

Nick Pattinson
Head of Product
Automata

Nick Pattinson is the head of product at Automata, a London-based biotech company providing robotic automation solutions to the life sciences industry. He is a trained mechanical engineer and studied at Oxford University. Pattinson joined Automata to help make real, tangible change and help unlock the potential of scientists through automation in laboratories.

Time and Date:

Wednesday, November 30, 2022 at 11 am ET | 10 am CT | 8 am PT

Sponsors:

Adare Pharma Solutions

Aizon

Festo

L.B. Bohle

Veltek Associates, Inc.

Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1581669&tp_key=e856000811